Prophylactic negative vacuum therapy of high-risk esophageal anastomoses in pediatric patients

J Pediatr Surg. 2021 May;56(5):944-950. doi: 10.1016/j.jpedsurg.2020.12.002. Epub 2020 Dec 13.

Abstract

Background: Esophageal anastomoses are at risk for leak or stricture. Negative pressure vacuum-assisted closure (VAC) therapy is used to treat leak. We hypothesized that a prophylactic VAC (pEVAC) at the time of new anastomosis may lead to fewer leaks and strictures.

Methods: Single center retrospective case-control study of patients undergoing high-risk esophageal anastomoses between July 2015 and January 2019. Outcomes of leak and long-term anastomotic failure (refractory stricture requiring surgery) were compared between groups.

Results: Sixteen patients had a pEVAC placed during LGEA repair (N = 10) or stricture resection (N = 6). Of pEVAC cases, 3 (N = 1 Foker, N = 2 stricture resections) experienced leak (18.8%). In comparison, leak occurred in 9/41 (22%) Foker patients and in 1/20 (5%) stricture resections without pEVAC, all p > 0.05. Long-term anastomotic failure was more common in the pEVAC cohort versus controls (56.3% versus 11.5%, p < 0.001).

Conclusions: Prophylactic EVAC placement does not appear to reduce leak and is associated with significantly greater odds of long-term anastomotic failure. Further device refinement could improve its potential role in prophylaxis of high-risk anastomoses, but future research is needed to better understand optimal patient selection, device design, and duration of pEVAC therapy.

Keywords: Esophageal atresia; Esophageal leak; Evac; Vacuum assisted closure.

MeSH terms

  • Anastomosis, Surgical
  • Anastomotic Leak / epidemiology
  • Anastomotic Leak / prevention & control
  • Case-Control Studies
  • Child
  • Humans
  • Negative-Pressure Wound Therapy*
  • Retrospective Studies
  • Treatment Outcome